Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

9 Items

per page
  1. KU-0063794
    A5078 KU-0063794
    Target: mTOR
    Summary: MTORC1 and mTORC2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.65 mg/mL
  2. Torin 1
    A8312 Torin 1
     7 Citation
    Target: mTOR
    Summary: MTOR inhibitor,potent and selective
  3. PP242
    A8318 PP242
    Target: mTOR
    Summary: MTOR inhibitor, selective and ATP-competitive
  4. WYE-125132 (WYE-132)
    B1642 WYE-125132 (WYE-132)
    Target: mTOR
    Summary: ATP-competitive mTOR inhibitor, highly potent
      insoluble in EtOH; insoluble in H2O; ≥13 mg/mL
  5. Torin 2
    B1640 Torin 2
     1 Citation
    Target: mTOR|DNA-PK|ATM/ATR
    Summary: MTOR inhibitor,highly potent and selective
      ≥21.6 mg/mL
  6. WAY-600
    B1641 WAY-600
    Target: mTOR
    Summary: MTOR inhibitor
      ≥12.38 mg/mL
  7. Rapamycin (Sirolimus)
    A8167 Rapamycin (Sirolimus)
     15 Citation
    Target: mTOR
    Summary: Original antifungal antibiotic
      ≥45.7 mg/mL
  8. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL
  9. Rapalink-1
    A8764 Rapalink-1
    Target: mTOR
    Summary: third-generation mTOR inhibitor
      ≥178.4 mg/mL

9 Items

per page